Medplus Health Services Board Meeting Outcome

Medplus Health Services Earnings Call Transcript: Key Takeaways

Medplus reported Q2 revenue of ₹2,037.1 Cr with 21.3% pharmacy growth, but EBITDA margins were hit by state-mandated wage hikes.

Call

Guides 10% growth

Medplus Health Services Share Pledge

Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).

Medplus Health Services Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹2,037cr (+21.3% YoY), operating EBITDA ₹98cr (4.8% margin), reported PAT ₹56cr (+1% YoY). Store expansion continues; no explicit guidance given.

Medplus Health Services Employee Stock Options

MedPlus allotted 19,095 equity shares to employees on exercise of ESOP 2021 options. Paid-up capital rises to Rs 24.03 Crore.

Medplus Health Services Q2 FY27 Results: Net Profit ₹56.1 Cr, Up 1.1% YoY

Medplus Health Services Ltd reported revenue from operations of ₹2,037 Cr (+21.3% YoY) and net profit of ₹56.1 Cr (+1.1% YoY) for Q2 FY27.

Key figure

Net profit ₹56.1 Cr · +1.1% YoY

Medplus Health Services Adverse Business Impact

Optival Health, a MedPlus subsidiary, had drug licences suspended at five Karnataka stores for 1–7 days. Expected impact is about Rs 8.66 lakhs.

Value

₹0.09 Cr

Execution

1 to 7 days per store

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.